Drug-Price Policy Discussions Are Focus Of MedPAC, Pew, Oncologists

By John Wilkerson / April 6, 2016 at 8:33 PM

Congressional Medicare advisers are scheduled Thursday (April 7) to take up draft recommendations on policy changes to drug reimbursement in both Medicare Part D and Part B, and they'll discuss policies that change how cancer doctors are paid for the drugs they administer.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.

FEATURES

NEWSLETTERS

ABOUT US

Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.

SITE LICENSES

Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.

STAY CONNECTED

Drug-Price Policy Discussions Are Focus Of MedPAC, Pew, Oncologists

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.